Tianchen Biotechnology is a biotech company founded in 2018 that focuses on advancing ophthalmology with comprehensive diagnostic and treatment solutions. The company specializes in the research, design, development, and sales of ophthalmology-related medical products, operating in the Biopharma and Biotechnology industries.
The latest significant funding round for Tianchen Biotechnology was a CNY100.00M Series A investment on 26th March 2024, which was led by China Merchants Bank International.
With a focus on providing complete diagnostic and treatment solutions for ophthalmology, this funding is expected to propel Tianchen Biotechnology forward in its mission to advance ophthalmic care and solidify its position in the biotechnology market.
